HomeAI · summaries
Storia in 2 fonti
VIDEO: Calabrese discusses FDA effort to withdraw avacopan approval, long COVID in ARDs
In this Healio video exclusive, Leonard H. Calabrese, DO, chief medical editor of Healio Rheumatology, highlights recent coverage regarding the FDA’s effort to revoke its approval of avacopan for ANCA-associated vasculitis.The FDA has alleged that employees of the drug’s original manufacturer, ChemoCentryx, manipulated data in the ADVOCATE trial, which was the sole study the FDA
Confronto fonti
2 prospettive sulla stessa storiaTimeline cronologica
- ·
healio.com
VIDEO: Calabrese discusses FDA effort to withdraw avacopan approval, long COVID in ARDs
In this Healio video exclusive, Leonard H. Calabrese, DO, chief medical editor of Healio Rheumatology, highlights recent coverage regarding the FDA’s effort to revoke its approval…
- ·
medpagetoday.com
FDA Gets New Avacopan Analysis After Alleging Data Manipulation
Agency has been calling for the vasculitis drug to be pulled from the market since January